The World Health Organization (WHO) estimates that about 254 and 304 million people globally are infected with chronic hepatitis B (HBV). Healthcare providers have diagnosed only 13% of the many individuals infected with HBV. Therefore, global health organizations are working to improve HBV screening and vaccination for adults and for those at high risk. As part of these efforts, doctors prescribe Hepbest Tablets for Hepatitis B treatment.
What is Tenofovir Alafenamide ?
It is an important antiviral medication used to treat chronic hepatitis B and HIV-1 infection. This medicine is from the drug class nucleoside reverse transcriptase inhibitors (NRTIs). It helps to prevent the virus from multiplying in the body. Additionally, Tenofovir Alafenamide (TAF) also serves an active ingredient for Tafero EM Tablet for Hepatitis B virus Infection.
What makes TAF so effective in treatment?
The primary reasons TAF is recognised for its effectiveness is the specific way in which it is delivered to the liver. Unlike older medications that release large doses of the medicine into the bloodstream, TAF is very stable in the plasma. It maintains this stability because it mainly travels through blood intact. And only after it has been delivered to the liver cells does it release the active antiviral.
According to the reports, this enables the achievement of a 90% lower dose with higher intracellular levels. By targeting the medicine to the site where the virus multiplies, it can inhibit virus replication precisely.
Is TAF Truly Faster than other treatments?
Studies show that this medicine treats chronic HBV infection more effectively than previous treatments. It also shows that TAF resulted in HBV suppression faster than other treatments in adults. For about 63% achieving suppression by week 48 compared to 43% for the older treatments. It also effectively normalises liver symptoms and often performs better than other treatments in restoring liver enzyme levels.
How does it protect bones and kidneys effectively?
This medicine has the potential for therapy that is not only faster, but also more sustainable. By maintaining low levels of this medicine in the blood streams, it minimises the side effects to other organs. As a result, patients taking TAF have noted improvements in overall kidney health. Compared to other treatments, it results in significantly less bone loss in both the hip and spine. Thus reducing the potential adverse effects on the aging patient population requiring long-term therapy.
Conclusion
This medicine is a huge step ahead in the treatment of HBV. The fact that it targets the liver directly without affecting the kidneys and bones is a much more efficient way of dealing with the virus. Although it is not a cure, its potency in quickly reducing the viral load and preserving overall health is the benchmark for many patients. If you want faster relief from this infection, you can get Hepbest 25mg price in discounted price at the official website of Magicine Pharma.
FAQs
1. Does this medicine cure hepatitis B?
A- No, this medicine cannot cure hepatitis B completely. Instead, it works by suppressing the virus to undetectable levels, which prevents liver damage and reduces the risk of liver cancer.
2. Can this medicine lower the risk of Liver Cancer?
A- Yes, this medicine lowers the risk of developing liver cancer in the long term by keeping undetectable viral loads.
